Latest stories on LEGN
Legend Biotech price target lowered to $74 from $78 at Barclays
The Fly42 · neutralanalyst
H.C. Wainwright reiterates Legend Biotech stock rating at buy
Investing.com Analyst Ratings61 · neutralanalyst
Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference
Business Insider56 · neutralgeneral
Legend Biotech Earnings Call Signals Profitable Growth
TipRanks65 · bullishearnings
Legend Biotech price target lowered to $24 from $29 at TD Cowen
The Fly38 · neutralanalyst
Legend Biotech price target lowered to $78 from $80 at Barclays
The Fly42 · neutralanalyst
Oppenheimer downgrades Legend Biotech to Perform on CEO/competition overhangs
The Fly38 · neutralanalyst
Wall Street Breakfast Podcast: Google Trots Out Legend To Inspire Gemini Devs
Seeking Alpha58 · neutralgeneral
Legend Biotech downgraded at Oppenheimer on CEO exit, competition
Seeking Alpha34 · bearishanalyst
Oppenheimer downgrades Legend Biotech stock rating on M&A concerns
Investing.com Analyst Ratings38 · neutralanalyst
Legend's Pipeline Is Starting To Matter
Seeking Alpha67 · bullishproduct/pr
Why is Legend Biotech stock sliding today?
Investing.com Markets34 · bearishgeneral
Legend Biotech (LEGN) Q2 2026 Earnings Call Transcript
The Motley Fool73 · bullishearnings
Legend Biotech Corporation 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Legend Biotech Corporation (LEGN) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Legend Biotech Gains 6% on Q2 Earnings Beat as Adjusted EPS Doubles Consensus
Yahoo Top68 · bullishearnings
Legend Biotech Shares Rise After Swinging to 2Q Profit, Higher Revenue
Morningstar67 · bullishearnings
Legend Biotech shares rise 5% as Q2 earnings and revenue beat estimates
InvestorsHub68 · bullishearnings
Legend Biotech shares rise 5% as Q2 earnings and revenue beat estimates
Yahoo Finance68 · bullishearnings
Legend Biotech Q2 Earnings Call Highlights
Yahoo Finance68 · bullishearnings
Why is Legend Biotech stock surging today?
Investing.com Markets50 · neutralgeneral
Legend Biotech Achieves Profitability and Breakthroughs in Cell Therapy with Q2 2026 Results
August 11, 2026
MarketChameleon76 · bullishearnings
Legend Biotech reports Q2 EPS 16c vs. 3c last year
The Fly73 · bullishearnings